01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $50.01B
1 older move runs past ±100% (largest +158.9%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $50.01B | −11.6% | 10-K | |
| FY2024 | $56.55B | −10.5% | 10-K | |
| FY2023 | $63.17B | +69.1% | 10-K | |
| FY2022 | $37.35B | +12.1% | 10-K | |
| FY2021 | $33.31B | +1.0% | 10-K | |
| FY2020 | $32.99B | +22.4% | 10-K | |
| FY2019 | $26.95B | −8.7% | 10-K | |
| FY2018 | $29.51B | −13.7% | 10-K | |
| FY2017 | $34.19B | +13.2% | 10-K | |
| FY2016 | $30.19B | +3.5% | 10-K | |
| FY2015 | $29.18B | −5.0% | 10-K | |
| FY2014 | $30.71B | +3.7% | 10-K | |
| FY2013 | $29.62B | +11.7% | 10-K | |
| FY2012 | $26.53B | +23.8% | 10-K | |
| FY2011 | $21.43B | +97.1% | 10-K | |
| FY2010 | $10.87B | +2.6% | 10-K | |
| FY2009 | $10.60B | +158.9% | 10-K | |
| FY2008 | $4.09B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is AMGEN INC's current long-term debt?
AMGEN INC (AMGN) annual long-term debt for 2025 was $50.01B, a 11.57% decline from 2024. AMGEN INC long-term debt for the quarter ending March 31, 2026 was $51.89B.
What was AMGEN INC's long-term debt in 2024?
AMGEN INC annual long-term debt for 2024 was $56.55B, a 10.48% decline from 2023.
What was AMGEN INC's long-term debt in 2023?
AMGEN INC annual long-term debt for 2023 was $63.17B, a 69.11% increase from 2022.
What is AMGEN INC's 5-year long-term debt CAGR?
AMGEN INC long-term debt grew at a compound annual growth rate (CAGR) of 8.68% from FY2020 to FY2025, going from $32.99B to $50.01B over 5 years.
- Company
- AMGEN INC
- Ticker
- AMGN
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)